These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 34387164)

  • 41. Changes in the pattern of respiratory diseases necessitating hospitalization of HIV-infected patients since the advent of highly active antiretroviral therapy.
    Dufour V; Cadranel J; Wislez M; Lavole A; Bergot E; Parrot A; Rufat P; Mayaud C
    Lung; 2004; 182(6):331-41. PubMed ID: 15765925
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Kaposi sarcoma of the eye in an HIV patient well-responded to HAART.
    Nelwan EJ; Pramono LA; Lubis AM; Djoerban Z
    Acta Med Indones; 2014 Jul; 46(3):253-5. PubMed ID: 25348189
    [No Abstract]   [Full Text] [Related]  

  • 43. Assessing the impact of HAART on the incidence of defining and non-defining AIDS cancers among patients with HIV/AIDS: a systematic review.
    Cobucci RN; Lima PH; de Souza PC; Costa VV; Cornetta Mda C; Fernandes JV; Gonçalves AK
    J Infect Public Health; 2015; 8(1):1-10. PubMed ID: 25294086
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The clinical profile of end-stage AIDS in the era of highly active antiretroviral therapy.
    Welch K; Morse A;
    AIDS Patient Care STDS; 2002 Feb; 16(2):75-81. PubMed ID: 11874639
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Incidence and prognosis of CMV disease in HIV-infected patients before and after introduction of combination antiretroviral therapy.
    Salzberger B; Hartmann P; Hanses F; Uyanik B; Cornely OA; Wöhrmann A; Fätkenheuer G
    Infection; 2005 Oct; 33(5-6):345-9. PubMed ID: 16258865
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Case report: dual primary AIDS-defining cancers in an HIV-infected patient receiving antiretroviral therapy: Burkitt's lymphoma and Kaposi's sarcoma.
    Kim SE; Jung Y; Oh TH; Kim UJ; Kang SJ; Jang HC; Park KH; Lee KH; Jung SI
    BMC Cancer; 2018 Nov; 18(1):1080. PubMed ID: 30409111
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Declining incidence of AIDS-defining opportunistic illnesses: results from 16 years of population-based AIDS surveillance.
    Schwarcz L; Chen MJ; Vittinghoff E; Hsu L; Schwarcz S
    AIDS; 2013 Feb; 27(4):597-605. PubMed ID: 23079812
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Uveitis as an initial manifestation of acquired immunodeficiency syndrome.
    Tsen CL; Chen SC; Chen YS; Sheu SJ
    Int J STD AIDS; 2017 Oct; 28(12):1224-1228. PubMed ID: 28201950
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Changing Global Epidemic of HIV and Ocular Disease.
    Peters RPH; Kestelyn PG; Zierhut M; Kempen JH
    Ocul Immunol Inflamm; 2020 Oct; 28(7):1007-1014. PubMed ID: 32396027
    [No Abstract]   [Full Text] [Related]  

  • 50. [Opportunistic eye diseases within the scope of HIV infection].
    Garweg J
    Klin Monbl Augenheilkd; 1993 May; 202(5):465-70. PubMed ID: 8377418
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The growth and the control of human immunodeficiency virus in the lung: implications for highly active antiretroviral therapy.
    White NC; Agostini C; Israel-Biet D; Semenzato G; Clarke JR
    Eur J Clin Invest; 1999 Nov; 29(11):964-72. PubMed ID: 10583442
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Oral candidiasis in human immunodeficiency virus-infected patients under highly active antiretroviral therapy.
    Shekatkar M; Kheur S; Gupta AA; Arora A; Raj AT; Patil S; Khan SS; Desai A; Carroll WB; Awan KH
    Dis Mon; 2021 Sep; 67(9):101169. PubMed ID: 33640178
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Neurological manifestations of HIV-infection in the era of highly active antiretroviral therapy (HAART)].
    Arendt G
    Fortschr Neurol Psychiatr; 2005 Oct; 73(10):577-86. PubMed ID: 16217698
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of GB virus C co-infection on response to generic HAART in African patients with HIV-1 clade C infection.
    Mosam A; Sathar MA; Dawood H; Cassol E; Esterhuizen TM; Coovadia HM
    AIDS; 2007 Jun; 21(10):1377-9. PubMed ID: 17545721
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Highly active antiretroviral therapy access and neurological complications of human immunodeficiency virus infection: impact versus resources in Brazil.
    Silva MT; Araújo A
    J Neurovirol; 2005; 11 Suppl 3():11-5. PubMed ID: 16540448
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Frequency and distribution patterns of opportunistic infections associated with HIV/AIDS in Uganda.
    Rubaihayo J; Tumwesigye NM; Konde-Lule J; Wamani H; Nakku-Joloba E; Makumbi F
    BMC Res Notes; 2016 Dec; 9(1):501. PubMed ID: 27927247
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The changing pattern of Kaposi sarcoma in patients with HIV, 1994-2003: the EuroSIDA Study.
    Mocroft A; Kirk O; Clumeck N; Gargalianos-Kakolyris P; Trocha H; Chentsova N; Antunes F; Stellbrink HJ; Phillips AN; Lundgren JD
    Cancer; 2004 Jun; 100(12):2644-54. PubMed ID: 15197808
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immune reconstitution syndrome after highly active antiretroviral therapy in human immunodeficiency virus-infected thai children.
    Puthanakit T; Oberdorfer P; Akarathum N; Wannarit P; Sirisanthana T; Sirisanthana V
    Pediatr Infect Dis J; 2006 Jan; 25(1):53-8. PubMed ID: 16395104
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lack of change in the distribution of AIDS-defining opportunistic diseases and the related degree of immunodeficiency during the periods before and after the introduction of highly active antiretroviral therapy.
    Manfredi R; Calza L; Chiodo F
    Eur J Clin Microbiol Infect Dis; 2001 Jun; 20(6):410-3. PubMed ID: 11476442
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Ocular manifestations in HIV/AIDS patients undergoing highly active antiretroviral treatment (HAART) in Togo].
    Ayena KD; Amedome KM; Agbo AR; Kpetessou-Ayivon AL; Dzidzinyo BK; Djagnikpo PA; Banla M; Balo KP
    Med Trop (Mars); 2010 Apr; 70(2):137-40. PubMed ID: 20486347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.